Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer ; day:14 ; month:1 ; year:2022 ; pages:1-11
European journal of nuclear medicine and molecular imaging ; (14.1.2022), 1-11
- Creator
-
Derks, Yvonne H. W.
Lith, Sanne A. M. van
Amatdjais-Groenen, Helene I. V.
Wouters, Lieke W. M.
Kip, Annemarie
Franssen, Gerben M.
Laverman, Peter
Löwik, Dennis W. P. M.
Heskamp, Sandra
Rijpkema, Mark
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-022-05685-0
- URN
-
urn:nbn:de:101:1-2022042819590993422988
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Derks, Yvonne H. W.
- Lith, Sanne A. M. van
- Amatdjais-Groenen, Helene I. V.
- Wouters, Lieke W. M.
- Kip, Annemarie
- Franssen, Gerben M.
- Laverman, Peter
- Löwik, Dennis W. P. M.
- Heskamp, Sandra
- Rijpkema, Mark
- SpringerLink (Online service)
Other Objects (12)
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy
Fucoidan-Based Theranostic Nanogel for Enhancing Imaging and Photodynamic Therapy of Cancer
Carbon Dots Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway
Structural modifications of PSMA ligands to optimize their pharmacokinetics
PSMA ligands for diagnosis and therapy of prostate cancer
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
Correction to: Carbon Dots Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?
Gold Nanostars-AIE Theranostic Nanodots with Enhanced Fluorescence and Photosensitization Towards Effective Image-Guided Photodynamic Therapy
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy
Fucoidan-Based Theranostic Nanogel for Enhancing Imaging and Photodynamic Therapy of Cancer
Carbon Dots Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway
Structural modifications of PSMA ligands to optimize their pharmacokinetics
PSMA ligands for diagnosis and therapy of prostate cancer
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
Correction to: Carbon Dots Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?
Gold Nanostars-AIE Theranostic Nanodots with Enhanced Fluorescence and Photosensitization Towards Effective Image-Guided Photodynamic Therapy
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy
Fucoidan-Based Theranostic Nanogel for Enhancing Imaging and Photodynamic Therapy of Cancer
Carbon Dots Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway
Structural modifications of PSMA ligands to optimize their pharmacokinetics
PSMA ligands for diagnosis and therapy of prostate cancer
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
Correction to: Carbon Dots Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?